RAC 3.33% $1.55 race oncology ltd

Ann: Race In-person Investor Briefing Invitation Perth, page-49

  1. 454 Posts.
    lightbulb Created with Sketch. 411
    Totally accept your proposition that JC sales are not a significant driver and, as you've said multiple times, company missteps are probably the significant underlying factor.

    I still consider that freely admitting a major shareholder is bailing out (but explaining why) is in line with the 'transparent' ethos the CEO seeks to trade on, and a useful means of building confidence, at least in retail investors. Even if there is limited upside prospect from this approach, there is no clear downside to telling that story I can see.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.